NewsCorporate ActionsBC Investments to Offload 2.4% Stake in Emcure Pharmaceuticals via Block DealBC Investments to Offload 2.4% Stake in Emcure Pharmaceuticals via Block Deal
By ScanX News Team
BC Investments, backed by Bain Capital, plans to sell approximately 45.5 lakh shares (2.4% stake) in Emcure Pharmaceuticals through a block deal. The offer price is set at ₹1,225.00 per share, a 4% discount to the current market price, with a total deal size of ₹551.00 crore. Kotak Securities will act as the book runner for the transaction scheduled for Friday. Emcure Pharmaceuticals recently reported strong Q4 results, with a 63% increase in net profit to ₹197.00 crore and a 19.5% rise in revenue to ₹2,116.00 crore.
*this image is generated using AI for illustrative purposes only.
Emcure Pharmaceuticals is set to witness a significant ownership change as BC Investments, backed by Bain Capital, prepares to sell a portion of its stake in the company through a block deal.
Block Deal Details
BC Investments plans to sell approximately 45.5 lakh shares, representing a 2.4% stake in Emcure Pharmaceuticals. The block deal is scheduled for Friday, with Kotak Securities acting as the book runner for the transaction.
Pricing and Deal Size
The offer price for the shares has been set at ₹1,225.00 per share, which represents a 4% discount to the current market price. This pricing strategy aims to attract potential buyers and ensure a smooth execution of the deal. The total size of the offer stands at an impressive ₹551.00 crore.
Recent Financial Performance
While not directly related to the block deal, it's worth noting that Emcure Pharmaceuticals has recently reported strong financial results for the fourth quarter:
| Financial Metric | Q4 Performance |
|---|---|
| Net Profit (PAT) | ₹197.00 crore (63% increase) |
| Revenue | ₹2,116.00 crore (19.5% increase) |
The company's robust financial performance may have contributed to the timing of this stake sale.
Market Impact
This block deal represents a significant transaction in the pharmaceutical sector and may attract attention from institutional investors. The discounted offer price could potentially lead to increased demand for the shares being offered.
As the market awaits the execution of this block deal, investors and industry observers will be keen to see how it impacts Emcure Pharmaceuticals' stock price and trading volumes in the coming days.
Historical Stock Returns for Emcure Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.72% | -2.93% | -3.23% | -12.64% | -5.84% | -5.84% |
17
